Oppenheimer Olson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Eli Lilly and Novo Nordisk, riding the wave of enthusiasm for obesity meds, are seeing their stock prices soar. But behind them are coming new therapies from.

United statesOppenheimer olsonJay olsonMadrigal pharmaceuticalsNovo nordiskEli lillyAmerican liver foundationMagnificent sevenViking therapeuticsArticle normalAgricultural machineryRetail wholesaleHealthcare life sciencesIndustrial goodsPolitical general newsSociety community